Navigation Links
VisEn Launches New VivoTag(R) 645 Fluorescence Molecular Imaging Label
Date:5/5/2010

BEDFORD, Mass., May 5 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence imaging from research through medicine, announced today the commercial launch of its new VivoTag® 645 red fluorescent dye for optimized labeling of biomolecules in a broad range of in vitro and in vivo research applications.  

The new VivoTag 645 represents VisEn's first agent offering in the lower-red wavelengths, enabling optimized and integrated imaging applications in both in vivo and in vitro research areas.  The VivoTag 645 is specifically designed for efficient and robust labeling of biomolecules, and is optimized for broad in vitro and in vivo imaging performance, including system compatibility, superior brightness, biocompatibility and stability in biological environments.  

"Our new VivoTag 645 represents an important evolution in our fluorescent imaging agent product line," said Kirtland Poss, President and CEO of VisEn Medical. "This new label is designed to be well-suited for applications both in vitro and in vivo research and we look forward to working closely with our customers in continually advancing these integrated research areas."

The new VivoTag 645 is particularly well suited for labeling and imaging of proteins, antibodies, and small molecules in a range of research areas.  The fluorescence wavelength is matched for biological imaging applications on in vitro and in vivo fluorescence systems, including advanced microscopes, high content imaging and flow cytometry systems. It is also optimized for use with VisEn's fluorescence tomography FMT™ imaging systems which also have
'/>"/>

SOURCE VisEn Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. VisEn Launches New Annexin-Vivo 750 Fluorescence Molecular Imaging Agent
2. VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent
3. VisEn Launches Next-Generation Fast (Fluorescence Activatible Sensor Technology) Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo
4. VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent
5. VisEn Medical Raises $7 Million in Series B Financing
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. BellBrook Labs Launches Compound Profiling Services with High Content 3D Invasion Assay
8. Ansell Launches Worldss First Antimicrobial Surgical Glove
9. ChromaDex Launches pTeroPure Pterostilbene
10. Vermont Launches Renewable Energy Atlas
11. DNA-Planet Launches New Service for Customer-Individual Indirect DNA Paternity Testing and Kinship Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... people over 60 are not donor candidates for bone ... time, making the elderly prone to life-threatening infection and ... now has discovered a reason why. , "We have ... blood-forming cells to maintain blood production over time in ... could be restored for rejuvenation therapies," said Emmanuelle Passegu, ...
(Date:7/31/2014)... 2014 The SNIS Foundation recognized its ... fund a translational research project.  The first award ... was presented at the Society of NeuroInterventional Surgery ... Colorado Springs, CO. ... neurovascular conditions, SNIS formed the SNIS Foundation, in ...
(Date:7/31/2014)... 31, 2014 According to a ... for Medical Devices Market (Diagnostic Electrodes - ECG, EEG, ... TENS, Pacemakers, Defibrillators, Electrosurgical and Other Electrodes) - Global ... - 2019," the global electrodes market for medical devices ... is estimated to reach a market worth USD 1,451.2 ...
(Date:7/31/2014)... SHENZHEN, China , July 31, 2014 /PRNewswire/ ... of an Irys™System by BGI , ... to enable comprehensive exploration of human structural variation (SV) ... of interest, including those where no reference exists. In ... new methods for multiplexing on the Irys System, enabling ...
Breaking Biology Technology:Key to aging immune system is discovered 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 2Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 3Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 4Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 5Electrodes for Medical Devices Market Expected to Reach USD 1.45 Billion Globally in 2019: Transparency Market Research 6BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4
... June 3 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: ... company that identifies,develops and commercializes differentiated products for ... clinical trials of its,anti-cancer drug nimotuzumab, a humanized ... were presented at the 2008 American,Society of Clinical ...
... 3 ViroPharma Incorporated,(Nasdaq: VPHM ) today ... of ViroPharma, will present at the Goldman Sachs ... on Tuesday, June 10,2008. The conference is being ... CA., ViroPharma also announced that William Roberts, ...
... FRANCISCO, Calif., June 3 Exelixis,Inc. (Nasdaq: EXEL ... chief executive officer of Exelixis, will present at the ... PT/2:00 p.m. ET on,Tuesday, June 10, 2008. Dr. Scangos ... strategy., The presentation will be webcast and may ...
Cached Biology Technology:NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 2NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 3NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 4ViroPharma to Present at Two Upcoming Healthcare Conferences 2
(Date:7/31/2014)... tracing nearly 3,000 genes to the earliest common ... scientists have created an extensive "Tree of Lepidoptera" ... DNA sequencing. , Among the study,s more ... small moths than to large ones, which completely ... study also found that some insects once classified ...
(Date:7/31/2014)... Researchers who studied 100 twin pairs have identified a ... on less than six hours of sleep per night. ... the effects of sleep deprivation. , Results show that a ... had an average nightly sleep duration of only five ... non-carrier twin, who slept for about six hours and five ...
(Date:7/31/2014)... researchers have completed a 20-year study that looks ... at different times of the year. It finds ... time frame has no measurable negative consequences for ... benefits. , The study was conducted by Gene ... Station fire chief, and Joseph Craine, research assistant ...
Breaking Biology News(10 mins):UF study advances 'DNA revolution,' tells butterflies' evolutionary history 2UF study advances 'DNA revolution,' tells butterflies' evolutionary history 3Study of twins discovers gene mutation linked to short sleep duration 2Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3
... Researchers used blood platelets and bone marrow cells ... of the human genetic disorder Hurler syndrome an ... medical complications. Scientists from Cincinnati Children,s Hospital Medical ... Stroke (NINDS) report their unique strategy for treating the ...
... 4, 2014) A new study by George Washington ... in the pathogenesis of prion disease misfolded proteins ... HIV virus. The research, published in the ... relationship between cholesterol metabolism and prion infection as a ...
... expected to decrease fitness, new research, published in Respirology ... motivation and are more likely to suffer symptoms of anxiety ... from Universidade Estadual de Londrina, Brazil, is the first study ... 60 smokers and 50 non-smokers were asked to wear ...
Cached Biology News:Mouse study shows gene therapy may be possible cure for Hurler syndrome 2GW researcher finds connection in pathogenesis of neurological diseases, HIV 2
... glutathione-S-transferase (GST) is commonly used as a ... coli (1). The GSTTag sequence has been ... some cases the solubility of its fusion ... folded form, GSTTag fusion proteins can be ...
... the next step in the evolution of ... system that delivers labware to multiple laboratory ... times the throughput of ordinary microplate robots. ... variety of configurations to meet any labs ...
... the use of small interfering RNA (siRNA) ... RNA interference (RNAi) pathway have generated tremendous ... fields. siRNA for experimental use can be ... and then transfected into the target cells ...
... The S&S Custom Array Service enables scientists ... analysis instrumentation to have FAST Slides printed with ... own library. Processing of the arrays is performed ... Contact S&S to discuss your needs with ...
Biology Products: